Dow Down 0.02% Nasdaq Down 0.16%

More On PBMD

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Prima Biomed Ltd. (PBMD)

-NasdaqGM
1.08 Down 0.03(2.70%) Aug 26 - Nasdaq Real Time Price
Prev Close:1.08
Open:1.08
Bid:1.06 x 3000
Ask:1.10 x 1900
1y Target Est:N/A
Beta:3.18
Next Earnings Date:N/A
Day's Range:1.06 - 1.15
52wk Range:0.82 - 2.49
Volume:69,404
Avg Vol (3m):45,906
Market Cap:44.23M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PBMD

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):24.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human cl... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback